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–calmodulin-dependent phosphorylation of my-
 
osin regulatory light chains by the catalytic COOH-
terminal half of myosin light chain kinase (MLCK)
 
activates myosin II in smooth and nonmuscle cells. In addi-
 
tion, MLCK binds to thin ﬁlaments in situ
 
 
 
and F-actin in
 
vitro via a speciﬁc repeat motif in its NH
 
2
 
 terminus at a
stoichiometry of one MLCK per three actin monomers.
We have investigated the structural basis of MLCK–actin
interactions by negative staining and helical reconstruc-
tion. F-actin was decorated with a peptide containing the
 
NH
 
2
 
-terminal 147 residues of MLCK (MLCK-147) that binds
 
to F-actin with high afﬁnity. MLCK-147 caused formation of
C
 
F-actin rafts, and single ﬁlaments within rafts were used for
structural analysis. Three-dimensional reconstructions showed
MLCK density on the extreme periphery of subdomain-1 of
each actin monomer forming a bridge to the periphery of
subdomain-4 of the azimuthally adjacent actin. Fitting the
reconstruction to the atomic model of F-actin revealed inter-
action of MLCK-147 close to the COOH terminus of the ﬁrst
actin and near residues 228–232 of the second. This
unique location enables MLCK to bind to actin without
interfering with the binding of any other key actin-bind-
ing proteins, including myosin, tropomyosin, caldesmon,
and calponin.
 
Introduction
 
Signal transduction pathways, linking extracellular stimuli to
intracellular processes, are essential for regulation of all cells.
Their effective operation requires complex spatial and tem-
poral organization that couples the component steps together.
Phosphorylation–dephosphorylation pathways, for example,
represent major cell control mechanisms, and generally the
effector kinases and phosphatases and their protein targets are
discretely compartmentalized in cells (Perry, 1983; Cohen,
2000). Myosin II activity, for example in smooth muscle and
 
nonmuscle cells, is regulated by phosphorylation, and the
kinase responsible is anchored on actin filaments.
Myosin regulatory light chains are phosphorylated by
Ca
 
2
 
 
 
–calmodulin-dependent myosin light chain kinase
(MLCK)* and dephosphorylated by a distinct form of phos-
phatase type 1 (for reviews see Kamm and Stull, 1985, 2001;
Sellers and Adelstein, 1986; Erdödi et al., 1996; Somlyo and
Somlyo, 2000). There is no troponin in smooth muscle, and
here, as in nonmuscle cells, Ca
 
2
 
 
 
 binds to its target protein,
 
calmodulin, as cytoplasmic Ca
 
2
 
 
 
 concentration increases after
cell stimulation. The Ca
 
2
 
 
 
–calmodulin complex then binds
to MLCK, leading to its activation, light chain phosphory-
lation, increased actin-activated myosin ATPase activity,
cross-bridge cycling on thin filaments, and contraction.
Both MLCK and phosphatase are modulated by phosphory-
lation and dephosphorylation, reactions mediated by signaling
networks (Stull et al., 1996, 1997; Somlyo and Somlyo,
2000; MacDonald et al., 2001).
There are two genes that express a skeletal muscle specific
MLCK and a smooth muscle MLCK, respectively. The
smooth muscle MLCK is ubiquitously expressed (Herring et
al., 2000) and consists of short and long isoforms due to
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multiple promoters in the gene (Kamm and Stull, 2001).
Short MLCK is present in smooth muscle cells at 
 
 
 
4 
 
 
 
M
(Hartshorne, 1987; Tansey et
 
 
 
al., 1994) in an approximate
molar ratio to myosin of 1:10 and to actin in filaments of
1:100. The short MLCK isoform found in smooth muscle
and some nonmuscle cells possesses an NH
 
2
 
-terminal actin-
binding extension (Kanoh et al., 1993; Gallagher and Stull,
1997; Ye et al., 1997), not present in skeletal muscle MLCK
(Nunnally and Stull, 1984; Lin et al., 1997), that localizes
the kinase to thin filaments, restricting its cellular mobility
(Guerriero et al., 1981; Dabrowska et al., 1982; Sellers and
Pato, 1984). The long MLCK is the same as the short
MLCK with additional actin-binding motifs and structural
modules at the NH
 
2
 
 terminus. The long MLCK has a
greater affinity for F-actin and is found primarily in non-
muscle cells (Kamm and Stull, 2001), where myosin II–
based motility is also regulated by light chain phosphoryla-
tion. The resulting compartmentalization of MLCK may be
involved in defining contractile regions in both smooth
muscle and nonmuscle cells.
The NH
 
2
 
-terminal extensions contain a novel high-affin-
ity actin-binding sequence, DFRXXL, which repeats three
times in short MLCK, leading to binding saturation of one
MLCK to three actin monomers along F-actin in vitro
(Smith et al., 1999; Smith and Stull, 2000). Mutating the
binding motifs significantly decreases association of MLCK
with myofilaments in vitro and with actin-containing fila-
ments in intact smooth muscle cells (Smith et al.., 1999).
The full-length short kinase is an elongated molecule, and
intervening PEVK, Ig-like, and fibronectin-like repeats be-
tween NH
 
2
 
-terminal and more COOH-terminal catalytic
domains are thought to provide sufficient extension for the
catalytic core to reach thick filaments abutting thin fila-
ments (Stull et al., 1996; Lin et al., 1999; Smith and Stull,
2000), thus allowing effective light chain phosphorylation of
cross-bridges. A COOH-terminal low-affinity myosin-bind-
ing fragment in MLCK (Sellers and Pato, 1984) may direct
the kinase towards myosin filaments, increasing the proba-
bility of myosin phosphorylation during activity, whereas
the NH
 
2
 
 terminus binds with sufficient high affinity to an-
chor the kinase to actin filaments. Additionally, since
MLCK apparently is not dissociated from thin filaments by
Ca
 
2
 
 
 
 or Ca
 
2
 
 
 
–calmodulin (Lin et al., 1999), the enzyme will
localize close to thin and thick filaments both at the onset
and during contractile activity.
Actin, the core of the thin filament, serves as a molecular
track for the myosin cross-bridge motor. Tropomyosin, also
present on thin filaments, ensures that on–off switching of
myosin ATPase and consequently contractility occurs coop-
Figure 1. Electron micrographs of negatively stained filaments. 
(a) Rabbit skeletal muscle F-actin alone (two examples). (b) Skeletal 
muscle F-actin–MLCK-147 (five examples). Note the increased di-
ameter of the decorated F-actin. Bar, 50 nm.
Figure 2. Transverse sections (z-sec-
tions) of 3-D reconstructions. (a) F-actin 
control. Because adjacent actin mono-
mers are staggered by  1/2   55 Å, 
sectioning the reconstruction through 
the widest part of one actin (monomer 
on the right) results in sectioning through 
a narrower part of the adjacent one (on 
the left); outer and inner domains are 
marked Ao and Ai on each. (b) F-actin–
MLCK-147; note the extra density (arrow) 
due to MLCK on the extreme periphery 
of the map bridging inner and outer 
domains of the two actin monomers 
sectioned. (c) Maps in a and b were 
compared, and the difference between 
the two (filled black region) was super-
imposed on a copy of the F-actin map. The difference densities, attributable to the bound MLCK, were statistically significant at  99.95% 
confidence levels. This analysis also showed that the protein-free pore between the MLCK density and F-actin (* in b; cross-hatching in c) was 
negatively significant, as if decorated filaments drew in extra stain in this region. Sections shown are at the same axial position and have the 
same relative orientation. The average phase residual (    SD), a measurement of the geometrical agreement among filaments generating re-
constructions, was 54.0   5.9  for the F-actin–MLCK-147 data. The average up–down phase residual (     SD), a measure of filament 
polarity, was 23.7   8.5 . The two values were comparable to those previously obtained. 
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eratively, narrowing the Ca
 
2
 
 
 
 concentration range required
for regulation (Lehman et al., 2000). Smooth muscle and
nonmuscle thin filaments also contain the protein caldesmon
and smooth muscle filaments calponin, both often implicated
in the regulation of thin filaments but of uncertain function
despite extensive biochemical characterization (Marston and
Huber, 1996; Chalovich et al., 1998; Marston et al., 1998;
Winder et al., 1998). Structural information on the interac-
tions of each of these proteins with F-actin has been extracted
from three-dimensional (3-D) reconstructions (Vibert et al.,
1993; Whittaker et al., 1995; Hodgkinson et al., 1997a,b;
Lehman et al., 1997; Volkmann et al., 2000). Together, these
proteins and myosin cover and/or move over much of the
outer face of actin, leaving little room free for extra binding
proteins, hence raising the possibility of a structural competi-
tion and functional clash with actin-bound MLCK. In the
current report, the interactions of MLCK on F-actin were ex-
amined structurally. The site of MLCK binding was deter-
mined by electron microscopy and 3-D reconstruction to as-
 
sess if MLCK is specifically and uniquely localized on
F-actin. We found that MLCK associates between laterally
adjacent actin monomers on F-actin, over an unoccupied
patch far from the myosin-binding site and from sites occu-
pied by tropomyosin, caldesmon, and calponin on actin.
Hence, MLCK binding should not interfere sterically with
myosin cross-bridge cycling, cooperative activation by tro-
pomyosin, or the operation of caldesmon or calponin.
 
Results and discussion
 
Electron microscopy of F-actin–MLCK-147 complexes
 
F-actin was complexed with peptide containing the NH
 
2
 
-
terminal 147 residues of MLCK (MLCK-147) under condi-
tions that should saturate filaments with the protein. Elec-
tron micrographs of negatively stained filaments showed
that the MLCK peptide caused extensive cross-linking of
F-actin into loosely packed bundles and rafts. Only unbun-
dled filaments within aggregates or those splaying off later-
ally were analyzed. Actin substructure, although evident, was
frequently obscured by the binding of the MLCK-147 on
the surface of filaments (Fig. 1), which also caused them to
appear wider than pure F-actin. Globular structures were oc-
casionally seen projecting from filaments but details of the
shape, orientation, and periodicity of the MLCK peptide
were not discernable. To detect the MLCK binding and de-
termine its position on F-actin, image processing and 3-D
reconstruction were therefore necessary.
 
3-D reconstructions of reconstituted thin filaments
 
Electron micrographs of two different sets of F-actin–
MLCK-147 were analyzed independently by the first and
last authors. Density maps of reconstituted filaments were
calculated from the averages of the Fourier transform layer
line data (not shown). All maps obtained showed typical
two-domain actin monomers that could be further divided
into identifiable subdomains (Figs. 2 and 3). When com-
pared with maps generated from pure F-actin controls, each
separately calculated reconstruction showed obvious extra
density lying between the inner domain of one actin and the
outer domain of the next monomer along the left-handed
genetic helix of F-actin (Figs. 2 and 3, arrows). Since the two
data sets were so similar, they were combined for further
analysis. The extra mass, attributable to the MLCK peptide,
and its location became especially apparent when difference
densities computed between maps of F-actin–MLCK-147
and F-actin were superimposed on the F-actin reconstruc-
tions (filled black region in Figs. 2 and 3, respectively). The
computed difference densities were statistically significant at
confidence levels 
 
 
 
99.95%. The statistical analysis con-
firmed that the only significant difference between the con-
trol and MLCK maps was the mass bridging successive
monomers. Inspection of the surface views of reconstruc-
tions (Fig. 3) showed that part of the MLCK density is
connected to a relatively broad part of the back of actin sub-
domain-1. The opposite side of MLCK approaches a protu-
berance on the bottom of subdomain-4 of the next actin
monomer along the F-actin genetic helix (subdomains noted
on four successive actin monomers). The MLCK density
therefore appears to link respective monomers together.
Figure 3. Surface views of thin filament reconstructions showing 
the position of the MLCK-147 peptide on F-actin. (a) F-actin control; 
actin subdomains are noted on four of the successive actin monomers 
(subscripts distinguish the particular monomer labeled; monomers 
with odd-numbered subscripts present face-on views of actin, and 
ones with even-numbered subscripts show reverse-side views). 
(b) MLCK-147–decorated F-actin; note the extra mass (arrows) not 
present in control filaments that link the bottom of subdomain-4 of 
each actin monomer to the back of subdomain-1 of the adjacent 
one. (c) To further define the relative position of MLCK-147, differ-
ence densities (filled black region) were calculated as described 
above and then superimposed on the F-actin reconstruction. Again, 
note the position of the difference density bridging between neigh-
boring monomers and then extending downward toward the barbed 
end of the filament. Connectivity was not noted between axially 
adjacent MLCK-147 densities, and therefore the results did not allow 
us to determine if the MLCK peptide is arranged longitudinally 
along F-actin as suggested by binding studies (Smith and Stull, 
2000). However, any possible linkage, predicted by Smith and Stull 
(2000), between successive binding domains may have been too 
thin or too disordered to be detected by the methods applied. 
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Fitting MLCK on the atomic model of F-actin
 
To further define the MLCK-147 binding site on F-actin, the
MLCK difference densities were localized on the refined
atomic model of F-actin (Lorenz et al., 1993) by fitting the
atomic model within the envelope formed by the actin compo-
nent of our reconstructions (compare with Vibert et al., 1997).
The fitting (Fig. 4) indicated that one side of MLCK-147 (red)
attached to COOH-terminal residues on subdomain-1 of one
actin monomer and that the opposite side of the peptide
closely approached an 
 
 
 
-helix (representing actin residues
228–232) protruding from subdomain-4 of the neighboring
monomer. The MLCK binding site is distinct from consensus
actin binding sites previously observed (McGough, 1998).
 
Molecular model of MLCK–actin binding
 
Circular dichroism studies indicate that MLCK-147 is
largely unstructured without 
 
 
 
-helix and 
 
 
 
-sheet content
(unpublished data). Despite this, our observations here indi-
cate that, once associated with F-actin, MLCK-147 assumed
a fairly compact shape, as if a structured conformation was
induced by binding to actin. Further inspection of the resi-
 
dues involved in the docking site of MLCK on actin re-
vealed a stretch of charged and hydrophobic residues at the
COOH-terminal region of F-actin complementary to those
in the MLCK-147 binding motif, suggesting that binding
might occur as illustrated in the model in Fig. 5, in which
the DFRXXL residues of MLCK-147 associate with the
Arg374, Val372, Glu366, and Tyr364 of actin, respectively.
 
Comparison of binding of MLCK and other
actin-binding proteins
 
The amount of MLCK in smooth muscle and nonmuscle
cells is substantially less than the amount of actin-binding
sites (Hartshorne, 1987; Stull et al., 1998), and it is therefore
likely that MLCK will be targeted to actin filaments partici-
pating in myosin II–based motility (compare with North et
al., 1994a; Kamm and Stull, 2001). These filaments contain
several actin-binding proteins involved in regulating thin fila-
ment function that could potentially compete with MLCK
for actin-binding sites. Since the locations of all major
smooth muscle and key nonmuscle thin filament-associated
proteins are known, their binding and that of MLCK could
be compared structurally. Inspection of Fig. 6, a composite
of difference density maps localizing the myosin binding site
and positions of tropomyosin, caldesmon, calponin, and
Figure 4. Location of MLCK-147 densities on the atomic structure 
of F-actin. The atomic model of F-actin (Lorenz et al., 1993) was fit-
ted to the EM reconstructions as previously described (Vibert et al., 
1997), and the location of the MLCK difference density on the atomic 
model was established. Two neighboring actin monomers are dis-
played as  -carbon chains: one in green (face-on view of actin) and 
the other in yellow (reverse-side view; note that these two monomers 
correspond to actin monomers 1 and 2 in Fig. 3). The fitted MLCK 
density (red) approaches an  -helix projecting from actin subdomain-4 
on one monomer (residues 228–232 highlighted in magenta) and 
comes into close contact with the COOH-terminal  -helix of actin 
subdomain-1 on the other (residues 364–375 highlighted in white). 
Without an atomic model of MLCK-147 available as a reference for 
molecular fitting, an exact description of the volume, shape, orienta-
tion, and contact points of the MLCK density on F-actin is precluded 
by the resolution and positional accuracy of the data.
Figure 5. Space-filling model of actin showing possible sites of 
interaction with the MLCK-binding motif. The amino acid sequence 
and 3-D structure of chicken aortic actin were evaluated in light of 
both the molecular fitting depicted in Fig. 4 and data on the 
DFRXXL binding motif. The space-filling model shows that the 
COOH-terminal actin residues Arg374 (green), Val372 (yellow), 
Glu366 (magenta), and Tyr364 (off-white) on the actin surface 
could make alternating electrostatic and hydrophobic interactions 
with DFRXXL (drawn schematically). If this were true, then the 
apparent binding to residues 228–232 of a laterally adjacent actin 
monomer (as in Fig. 4) would occur with flanking amino acids of 
the MLCK-147 construct. 
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MLCK-147 on F-actin, demonstrates that the MLCK dock-
ing site is distinct from that of the others. The absence of any
steric clash between the binding of MLCK and the other ac-
tin-binding proteins would favor the stability of the MLCK
interaction. Moreover, the unique binding of MLCK would
not interfere with myosin docking and cycling on actin. It is
noteworthy that caldesmon and calponin densities do over-
lap structurally with each other (Fig. 6), consistent with sig-
nificant binding competition of caldesmon and calponin ob-
served in vitro and histological segregation in vivo (Fürst et
al., 1986; Small et al., 1986; Lehman, 1991; Makuch et al.,
1991; North et al., 1994a,b); in contrast, MLCK binding
to native smooth muscle thin filaments is not blocked by
the presence of tropomyosin, caldesmon, and/or calponin
(Smith et al., 1999). Together, studies on the structure of
smooth muscle thin filaments demonstrate that actin-bind-
ing proteins adopt characteristic positions on the thin fila-
ment consistent with distinct functions. In the case of the
short MLCK in smooth muscle, its NH
 
2
 
-terminal structural
domain is anchored to a site where no other actin-binding
protein to date has been localized (compare with
 
 
 
McGough,
1998). The long MLCK present in nonmuscle cells has two
additional DFRXXL actin-binding motifs, and thus, it is pre-
dicted that its location will be similar except for a maximal
stoichiometry of one long MLCK per five actin monomers in
the thin filament. In both the short and long MLCKs, the in-
tervening PEVK, Ig-like, and fibronectin modules would ex-
tend the catalytic core to myosin thick filaments, thereby
allowing regulatory light chain phosphorylation upon activa-
tion by Ca
 
2
 
 
 
–calmodulin. The design of the MLCK mole-
cule is therefore well adapted for its part in the cascade of
events leading to myosin II–based cellular motility.
 
Materials and methods
 
Protein preparation
 
Construction and expression of MLCK-147: the cDNA fragment of the
NH
 
2
 
-terminal 1–147 amino acids of rabbit smooth muscle MLCK was am-
plified by PCR and subcloned into TOPO cloning vector pCR 2.1 (Invitro-
gen). After sequencing, the cDNA was then subcloned into the expression
vector pET 28a (Novagen) with a His-tag sequence at the NH
 
2
 
 terminus of
MLCK-147. The expression constructs were transformed into bacteria
strain BL21 (DE3), and protein expression was induced by IPTG. After cen-
trifugation, the cells were resuspended in 20 mM Tris/HCl, pH 7.0, 1 mM
EDTA, and 0.1% NP-40, sonicated, and centrifuged again. The soluble
MLCK-147 peptide was purified by His-Bind Quick column as described
by the manufacturer (Novagen). The purified MLCK-147 binds to F-actin
with a 
 
K
 
d
 
 value of 0.26 
 
  
 
0.01 
 
 
 
M and a stoichiometry of one MLCK-147
to three actin molecules. MLCK-147 contains the three DFRXXL motifs
present in the 75–amino acid NH
 
2
 
-terminal fragment studied by Smith and
Stull (2000).
Rabbit skeletal muscle F-actin was purified by standard methods (Spu-
dich and Watt, 1971). The F-actin used was stable and did not aggregate,
an advantage for the structural studies performed. Different actin isoforms
are highly conserved (we used skeletal muscle 
 
 
 
-actin in our studies); iso-
form variability, in fact, occurs mainly at the acidic NH
 
2
 
-terminal six
amino acids of actin (Vanderkerckhove and Weber, 1978; Lehman et al.,
1996) whose position is distal from the site of MLCK-147 binding (see Re-
sults and discussion). There were no significant differences in binding af-
finity of NH
 
2
 
-terminal MLCK fragments to skeletal muscle F-actin and de-
tergent washed native smooth muscle myofilaments; the stoichiometry of
binding was the same (Smith and Stull, 2000; unpublished data).
 
Electron microscopy and helical reconstruction
 
F-actin (1 
 
 
 
M) was decorated with excess MLCK-147 (2 
 
 
 
M) in solutions of
50 mM KCl, 1 mM EGTA, 1 mM MgCl
 
2
 
, 0.2 mM ATP, 1 mM DTT, 10 mM
imidazole buffer (pH 7.2) at room temperature (
 
 
 
25°C). Reconstituted fila-
ments were immediately applied to carbon-coated electron microscope
grids and negatively stained as previously described (Moody et al., 1990).
Prolonged decoration was avoided, since F-actin and MLCK-147 incubated
together for as short as 5 min formed very large and unusable filament ag-
gregates. Electron micrograph images of decorated filaments were recorded
on a Philips CM120 electron microscope at 60,000
 
 
 
 magnification under
low-dose conditions (
 
 
 
12e
 
 
 
/Å
 
2
 
). Micrographs were digitized using a ZEISS
SCAI scanner at a pixel size corresponding to 0.7 nm in the filaments. Well-
stained regions of filaments were selected and straightened as previously
described (Egelman, 1986; Hodgkinson et al., 1997a). Helical reconstruc-
tion was carried out by standard methods (DeRosier and Moore, 1970;
Amos and Klug, 1975; Owen et al., 1996) as previously described (Vibert et
al., 1993, 1997). Two independently analyzed sets of filaments totaling 28
filaments were chosen for averaging, based on their relative phase agree-
ment. The reconstruction had a resolution (Owen and DeRosier, 1993) of
2.5–3.0 nm; the positional accuracy of the method is 
 
 
 
0.5 nm (Milligan et
al., 1990). Difference density analysis to define MLCK position on actin was
carried out as previously described (Xu et al., 1999), and differences be-
tween maps were evaluated statistically using a Student’s 
 
t
 
 test (Milligan
and Flicker, 1987; Trachtenberg and DeRosier, 1987). Fitting of reconstruc-
tions to the atomic resolution structure of F-actin (Lorenz et al., 1993) was
carried out as previously described (McGough and Way, 1995; Vibert et al.,
1997; Xu et al., 1999) using the program O (Jones et al., 1991).
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